Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/2360
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBobomuratov T.A., Bakirova M.A.-
dc.date.accessioned2025-11-13T09:30:27Z-
dc.date.available2025-11-13T09:30:27Z-
dc.date.issued2025-
dc.identifier.urihttp://repo.tma.uz/xmlui/handle/1/2360-
dc.description.abstractCovid-19 qo’zg’atuvchisi qon-tomirlarda yallig’lanishni chaqiradi va qon ivishini oshiradi. Covid-19ning og’ir formalarida shiddatli yallig’lanish oqibatida giperkoagulyasiya, trombotik mikroangiopatiyalar, tromboz va DVS sindrom rivojlanishi kuzatildi. Maqsad: Covid-19 kasalligini o‘tkazgan bolalarni tiklanish davrida asoratlar rivojlanishining xavf omillarini aniqlash. Material va usullar: Tekshiruv ob'yekti 129 ta 1yoshdan 18 yoshgacha bo‘lgan, Covid-19 kasalligini o‘tkazgan bolalar va nazorat guruhi sifatida 20 ta shu yoshdagi sog‘lom bolalar. Natijalar: Tiklanish davrida giperkoagulyatsiya jarayoni bilan kechgan xolatda bolalarda gemostaz tizimining koʼrsatkichlarini tahlil qilinganda, trombotsitlar sonining 1,6 baravar koʼpayishi (nazorat guruhida 281,3 ± 11,3 x 109 / l ga nisbatan asosiy guruhda 362,1 ± 7,7 x 109 /l ga) aniqlangan. Xulosa: SARS-CoV-2 bolalarda qon tomirlarni shikastlashi mumkin va kelajakda gipertoniya, o’pka gipertenziyasi, insult, surunkali buyrak kasalligi rivojlanishi mumkinen_US
dc.language.isootheren_US
dc.publisherO'zbekiston, Аndijonen_US
dc.relation.ispartofseriesUO’K:;616.98-036.22-053.2-036:616-083-
dc.subjectCovid-19, bolalar, giperkoagulyasiya, gemostaz, yallig’lanish, tiklanish davri.en_US
dc.titleBOLALARDA COVID-19 KASALLIGIDAN SO‘NG TIKLANISH DAVRIDA ASORATLAR RIVOJLANISHINING XAVF OMILLARIen_US
dc.typeArticleen_US
Appears in Collections:Articles

Files in This Item:
File Description SizeFormat 
JMM №3 (10) (3).pdfBOLALARDA COVID-19 KASALLIGIDAN SO‘NG TIKLANISH DAVRIDA ASORATLAR RIVOJLANISHINING XAVF OMILLARI9.44 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.